OHP, INC. – Trademark Portfolio
Entity Type: 03
OHP, INC. holds 51 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 42 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 27 trademarks are registered and 2 are pending. Notable registered marks include OHP, JUDO, ARECA, ASTUN, and SEIDO. The owner is based in MAINLAND, PA.
P.O. BOX 230
MAINLAND, PA 194510230
Showing of trademarks Trademarks
Trademark Classifications
OHP, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Advertising; business management; business administration; office functions
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does OHP, INC. have?
OHP, INC. has 51 U.S. trademarks filed with the USPTO. Of these, 27 registered, 2 pending, 13 abandoned, 9 cancelled.
What trademark classes does OHP, INC. file in?
OHP, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 35 (Advertising & Business), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are OHP, INC.'s most well-known trademarks?
OHP, INC.'s registered trademark portfolio includes well-known marks such as OHP, JUDO, ARECA, ASTUN, and SEIDO. These are among 27 currently registered trademarks in the portfolio.
What is OHP, INC.'s trademark registration success rate?
OHP, INC. has a 55% trademark registration rate, with 27 out of 49 resolved applications resulting in successful registration. Currently, 2 applications are pending review.